Transcutaneous Pulsed Radiofrequency in Migraine

Diskapi Teaching and Research Hospital

Status: Active, not recruiting

Conditions: Migraine Disorders

Treatments: Other: Transcutaneous pulsed radiofrequency qurrent; Drug: Bupivacaine Hydrochloride

Study type: Interventional

Funder types: Other

Identifiers

NCT05499689

Transcutaneous GON

Details and patient eligibility

About

The aim of the investigator is to compare the efficacy of greater occipital nerve block and transcutaneous pulsed radiofrequency treatment in migraine.

Full description

Migraine is the second most common primary headache. Greater occipital nerve (GON) block is an effective method in the treatment of migraine. Transcutaneous pulsed radiofrequency (RF) therapy is used in the treatment of pain. However, its use in headaches is not widespread yet.

Investigator aimed to compare the efficacy of transcutaneous pulsed radiofrequency therapy applied through the GON trace and GON block therapy. A 60-patient study was designed. GON block was planned for 30 patients and transcutaneous pulsed RF was planned for 30 patients. The block will be applied once at the level of C2 vertebra with ultrasound.Transcutaneous pulsed RF will be applied twice, once a week, for 8 minutes.All patients will have pre-treatment migraine disability assessment score (MIDAS) scores filled. A headache diary will be provided to all patients. Frequency and severity of pain will be followed for 1 month. Pain intensity will be evaluated on the visual analog scale (VAS).

Investigator aimed to evaluate the efficacy of transcutaneous pulsed RF therapy, which is a noninvasive method, in migraine.

Enrollment: 60 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic Migraine

Exclusion criteria

• Other headaches will not accompany (tension-type headache, cluster...)
• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

60 participants in 2 patient groups

GON block group

Active Comparator group

Description:

30 patients who underwent greater occipital nerve block

Treatment:

Drug: Bupivacaine Hydrochloride

Transcutaneous pulsed RF group

Active Comparator group

Description:

30 patients who underwent greater occipital nerve pulsed radiofrequency

Treatment:

Other: Transcutaneous pulsed radiofrequency qurrent